ArticleThe Journal of investigative dermatology2020
Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting.
Abstract read
In one paragraph
Article in The Journal of investigative dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Sancy A LeachmanDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Thomas J HornyakResearch and Development Service, VA Maryland Health Care System, Baltimore, Maryland; Departments of Dermatology and Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
Greg BarshHudsonAlpha Institute for Biotechnology, Huntsville, Alabama; Department of Genetics, Stanford University, Stanford, California.
Boris C BastianHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
Douglas E BrashDepartments of Therapeutic Radiology and Dermatology and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
James E CleaverDepartment of Dermatology, University of California, San Francisco, San Francisco, California.
Cynthia D CooperSchool of Molecular Biosciences and College of Arts and Sciences, Washington State University Vancouver, Vancouver, Washington.
John A D'OrazioThe Markey Cancer Center and the Departments of Toxicology and Cancer Biology and Pediatrics, University of Kentucky College of Medicine, Lexington, Kentucky.
Mayumi FujitaDepartments of Dermatology and Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado; Denver VA Medical Center, Denver, Colorado.
Sheri L HolmenHuntsman Cancer Institute and Departments of Oncological Sciences and Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah.
Arup K IndraDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, and Molecular and Cellular Biology Program, Oregon State University, Corvallis, Oregon.
Kenneth H KraemerLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
I Caroline Le PooleOncology Research Institute, Loyola University Chicago, Maywood, Illinois; Departments of Dermatology and Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Roger S LoDivision of Dermatology, Department of Medicine, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California.
Amanda W LundDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon.
Prashiela MangaRonald O. Perelman Department of Dermatology and Department of Cell Biology, New York University School of Medicine, New York, New York.
William J PavanGenetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
Vijayasaradhi SetaluriDepartment of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin.
Clara E StemwedelDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
Molly F Kulesz-MartinDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon. Electronic address: kuleszma@ohsu.edu.
Funding
Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5MYale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MYale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI RUTH HALABAN · 2006 to 2026
$43.9MDNA Repair in Human Cancer-Prone Genetic DiseasesZIABC004517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRAEMER, KENNETH H · 2009 to 2024
$26.5MModulation of Inflammasome-mediated cytokine activation by EGCG in human melanomaR01CA197919 · NCI · UNIVERSITY OF COLORADO DENVER · PI FUJITA, MAYUMI · 2016 to 2020
$1.9MIdentification and Characterization of Melanocyte Stem CellsR01AR064810 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI HORNYAK, THOMAS J · 2014 to 2018
$1.7MChemiexcitation: A New Mode of Skin DiseaseR01AR070851 · NIAMS · YALE UNIVERSITY · PI BRASH, DOUGLAS E · 2017 to 2020
$1.7MMontagna Symposium on the Biology of SkinR13AR009431 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SANCY ANN LEACHMAN · 1986 to 2026
$785k2018 PASPCR Annual Meeting: "Melanoma to Vitiligo: The Melanocyte in Biology & Medicine"R13AR074279 · NIAMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEACHMAN, SANCY ANN · 2018 to 2018
$18kMelanocyte Stem Cells in Regenerative MedicineI01BX002582 · VA · BALTIMORE VA MEDICAL CENTER · PI HORNYAK, THOMAS J · 2015 to 2023
–BLRD VA I01 BX002582NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016042NCI NIH HHS P50 CA121974NCI NIH HHS R01 CA197919NIAMS NIH HHS R01 AR064810NIAMS NIH HHS R01 AR070851NIAMS NIH HHS R13 AR009431NIAMS NIH HHS R13 AR074279
Abstract
PubMed holds no abstract for this paper.
Indexed as
Congresses as TopicSkin PigmentationAnimalsBiomedical ResearchDisease Models, AnimalHumansMelanocytesMelanomaSocieties, ScientificVitiligo
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.